Dr. Satish N. Nadig
MD Ph.D FACS
Surgery, Microbiology/Immunology, & Pediatrics
Satish N. Nadig is the Edward G. Elcock Professor of Surgery at the Northwestern University-Feinberg School of Medicine-USA.
He is a well-known multiorgan transplant surgeon (adult & pediatric) and Professor in the Departments of Surgery, Microbiology/Immunonology, and Pediatrics.
He currently serves as the Director of the Comprehensive Transplant Center and Chief of the Division of Transplant Surgery.
Dr. Nadig directs the NIH-funded Comprehensive Transplant Immunobiology Laboratory and holds a Doctor of Philosophy in immunology from Oxford.
He has served as a national and international visiting professor and has been identified as a “Key Opinion leader” in the Transplantation Society as well as a leader in the American Society of Transplant Surgeons.
Dr. Nadig is the Chief Medical Advisor to Pandorum Technologies, Ltd, Pvt. and his research interests are focused on innovations in transplantation tolerance including cellular therapy, nanotechnology, and transplant immunology.
Dr. Nadig was named as one of Charleston, South Carolina’s (his home State) Forty under 40 in 2015, is featured in a 2016 TEDx Talk on organ donation, and has a published textbook entitled Technological Advances in Organ Transplantation.
1. Education
- MD PhD: Medical University of South Carolina/BIDMC-Harvard University/ University of Oxford/University of Michigan (2003)
2. Honors and Awards
- Research Mentor of the Year Award, Northwestern University Feinberg School of Medicine (2023)
- Excellence in Teaching Award, Northwestern University Feinberg School of M (2023)
- Inducted into the Irmo High School Hall of Fame, Irmo High School, Columbia, South Carolina (2021)
- MUSC Chapter of the National Academy of Inventors, Medical University of South Carolina (2020)
- MUSC President’s Values in Action- Innovation Award, Medical University of South Carolina (2020)
3. Most Recent Publications
- Multiorgan transplant for therapy-associated lung and liver failure in a patient with stage III lung cancer. https://doi.org/10.1016/j.ajt.2024.09.007
- Advancing mouse models for transplantation research. https://doi.org/10.1016/j.ajt.2024.01.006
- Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation. https://doi.org/10.1016/j.ajt.2022.11.026
- Connexins in endothelial cells as a therapeutic target for solid organ transplantation. https://doi.org/10.1111/ajt.17104